Oncology & Cancer

Outlining the future of theranostics in neurooncology

Nuclear medicine has the potential to change the landscape of theranostics in neurooncology, according to a new article published in The Journal of Nuclear Medicine (JNM). With recent advances in techniques to permeate the ...

Oncology & Cancer

Immunotherapy for brain cancer metastases shows clinical benefit

In a phase 2 clinical trial of the immune checkpoint inhibitor pembrolizumab, investigators found that 42 percent of patients with metastatic brain cancer benefited from the therapy, with seven patients in the trial surviving ...

page 1 from 14